Global /China /Healthcare /Drug Manufacturers - General /000739
chevron_leftBack
Apeloa Pharmaceutical Co.,Ltd logo

Apeloa Pharmaceutical Co.,Ltd

000739
SHE: 000739 Delayed
18.27CNY -1.1%
2.70 USD
As of 5 June 2026, Apeloa Pharmaceutical Co.,Ltd has a market cap of $3.07B USD, ranking #5337 globally and #1141 in China. It ranks #415 in the Healthcare sector, and #162 in the Drug Manufacturers - General industry.
Global Rank
5337
Country Rank
1141
Sector Rank
415
Industry Rank
162
Key Stats
Market Cap
$3.07BUSD
20.8B CNY
Enterprise Value
$2.77BUSD
18.72B CNY
Revenue (TTM)
$1.4BUSD
9.5B CNY
EBITDA (TTM)
$241.26MUSD
1.63B CNY
Net Income (TTM)
$131.69MUSD
891.15M CNY
EBITDA Margin
17%
Profit Margin
9.4%
PE Ratio
23.8
Forward PE
16.2
PS Ratio
2.2
PB Ratio
3.2
EV/EBITDA
11.4
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Chun He open_in_new
Employees
6,787
Founded
1989
Website
apeloa.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-1.1% 0.4% 5.2% -1.5% 20% 36%

News

Loading...

Markets

Exchange Ticker Price
Shenzhen Stock Exchange
MIC: XSHE
PRIMARY
000739
普洛药业股份有限公司 Class A
ISIN: CNE000000Q45
Shares Out.:
1.126B1 Shares Float: 529.361M2
TV:
SA:
YF:
GF:
BA:
MS:
18.27 CNY
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Apeloa Pharmaceutical Co.,Ltd

Apeloa Pharmaceutical Co.,Ltd provides raw materials various pharmaceutical factories in the People’s Republic of China and internationally. The company operates through API, CDMO, and Pharmaceutical segments. It offers API intermediates business, which includes cephalosporin, penicillin, psychotropic, cardiovascular and cerebrovascular, and veterinary API intermediates series; innovative drug R&D and production services CDMO include R&D services, commercial human drug projects, commercial veterinary drug projects and other commercial projects; pharmaceutical business includes anti-infective, cardiovascular, psychotropic, hepatobiliary and anti-tumor categories. The company also provides technology platforms, such as flow chemistry, synthetic biology and biocatalysis, crystallization and particle engineering, peptide, high potency compound, conjugate library service, oligonucleotide synthesis, and preparation and purification; and controlled-release formulation development, taste masking technology, and particle flow simulation. In addition, it exports its products under the Tianliwei, Baishixin, Li'an, Jutai, and other brands. Apeloa Pharmaceutical Co.,Ltd was founded in 1989 and is based in Dongyang, the People’s Republic of China.

Similar Companies

Industry: Drug Manufacturers - General (China)
Name
Market Cap diff.
PE
$53.92B
364.89B CNY
2K%
44.9
603259
$49.7B
336.36B CNY
2K%
17.2
$28.52B
223.48B HKD
828%
35.7
$18.8B
147.32B HKD
512%
162.3
$16.53B
111.89B CNY
438%
-
9926
$16.01B
125.46B HKD
421%
-
Industry: Drug Manufacturers - General (Global)
Name
Market Cap diff.
PE
LLY
$761.68B
25K%
38.1
JNJ
$547.28B
18K%
26.4
ABBV
$360.63B
12K%
97.4
$323.4B
256.25B CHF
10K%
19.9
AZN
$289.25B
215.59B GBP
9K%
27.6
NOVN
$276.26B
218.9B CHF
9K%
20.5
chevron_leftBack